Similar articles for PMID: 12559844

Year	Number of Results
1947	1
1995	2
1996	1
1997	4
1998	3
1999	7
2000	2
2001	4
2002	6
2003	4
2004	5
2005	8
2006	3
2007	10
2008	10
2009	5
2010	4
2011	10
2012	2
2013	6
2014	6
2015	4
2016	4
2017	7
2018	10
2019	7
2020	6
2021	3
2022	8
2023	2
2024	0

1

Functional categorization of gene expression changes in the cerebellum of a Cln3-knockout mouse model for Batten disease.

Brooks AI, Chattopadhyay S, Mitchison HM, Nussbaum RL, Pearce DA. Brooks AI, et al. Mol Genet Metab. 2003 Jan;78(1):17-30. doi: 10.1016/s1096-7192(02)00201-9. Mol Genet Metab. 2003. PMID: 12559844

2

Altered gene expression in the eye of a mouse model for batten disease.

Chattopadhyay S, Kingsley E, Serour A, Curran TM, Brooks AI, Pearce DA. Chattopadhyay S, et al. Invest Ophthalmol Vis Sci. 2004 Sep;45(9):2893-905. doi: 10.1167/iovs.04-0143. Invest Ophthalmol Vis Sci. 2004. PMID: 15326100

3

Early changes in gene expression in two models of Batten disease.

Elshatory Y, Brooks AI, Chattopadhyay S, Curran TM, Gupta P, Ramalingam V, Hofmann SL, Pearce DA. Elshatory Y, et al. FEBS Lett. 2003 Mar 13;538(1-3):207-12. doi: 10.1016/s0014-5793(03)00162-5. FEBS Lett. 2003. PMID: 12633880 Free article.

4

Transcript and in silico analysis of CLN3 in juvenile neuronal ceroid lipofuscinosis and associated mouse models.

Chan CH, Mitchison HM, Pearce DA. Chan CH, et al. Hum Mol Genet. 2008 Nov 1;17(21):3332-9. doi: 10.1093/hmg/ddn228. Epub 2008 Aug 4. Hum Mol Genet. 2008. PMID: 18678598 Free PMC article.

5

Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease).

Seigel GM, Lotery A, Kummer A, Bernard DJ, Greene ND, Turmaine M, Derksen T, Nussbaum RL, Davidson B, Wagner J, Mitchison HM. Seigel GM, et al. Mol Cell Neurosci. 2002 Apr;19(4):515-27. doi: 10.1006/mcne.2001.1099. Mol Cell Neurosci. 2002. PMID: 11988019

6

Altered arginine metabolism in the central nervous system (CNS) of the Cln3-/- mouse model of juvenile Batten disease.

Chan CH, Ramirez-Montealegre D, Pearce DA. Chan CH, et al. Neuropathol Appl Neurobiol. 2009 Apr;35(2):189-207. doi: 10.1111/j.1365-2990.2008.00984.x. Neuropathol Appl Neurobiol. 2009. PMID: 19284480

7

Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected].

Mitchison HM, Bernard DJ, Greene ND, Cooper JD, Junaid MA, Pullarkat RK, de Vos N, Breuning MH, Owens JW, Mobley WC, Gardiner RM, Lake BD, Taschner PE, Nussbaum RL. Mitchison HM, et al. Neurobiol Dis. 1999 Oct;6(5):321-34. doi: 10.1006/nbdi.1999.0267. Neurobiol Dis. 1999. PMID: 10527801

8

An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease.

Chattopadhyay S, Ito M, Cooper JD, Brooks AI, Curran TM, Powers JM, Pearce DA. Chattopadhyay S, et al. Hum Mol Genet. 2002 Jun 1;11(12):1421-31. doi: 10.1093/hmg/11.12.1421. Hum Mol Genet. 2002. PMID: 12023984

9

High resolution MRI reveals global changes in brains of Cln3 mutant mice.

Greene ND, Lythgoe MF, Thomas DL, Nussbaum RL, Bernard DJ, Mitchison HM. Greene ND, et al. Eur J Paediatr Neurol. 2001;5 Suppl A:103-7. doi: 10.1053/ejpn.2000.0444. Eur J Paediatr Neurol. 2001. PMID: 11588978

10

Altered flurothyl seizure induction latency, phenotype, and subsequent mortality in a mouse model of juvenile neuronal ceroid lipofuscinosis/batten disease.

Kriscenski-Perry E, Applegate CD, Serour A, Mhyre TR, Leonardo CC, Pearce DA. Kriscenski-Perry E, et al. Epilepsia. 2002 Oct;43(10):1137-40. doi: 10.1046/j.1528-1157.2002.16002.x. Epilepsia. 2002. PMID: 12366726 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

141 results

Results by year